Korsana Biosciences, Inc.(KRSA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Korsana Biosciences, Inc. (KRSA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KRSA at 19.3/100 on a 32-signal composite quality model, placing it at rank #2,729 of 2,891 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Korsana Biosciences, Inc. reports net income of $-1.8M, free cash flow of $-1.4M. Top institutional holders of KRSA by reported 13-F value include Kalehua Capital Management, FMR, BALYASNY ASSET MANAGEMENT L.P., based on the most recent SEC filings. KRSA trades on the Nasdaq exchange and files with the SEC under CIK 1755237. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KRSA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Korsana Biosciences, Inc. directly from SEC EDGAR.